IGFBP-3 methylation-derived deficiency mediates the resistance to cisplatin through the activation of the IGFIR/Akt pathway in non-small cell lung cancer.

Saved in:

Bibliographic Details
Title:	IGFBP-3 methylation-derived deficiency mediates the resistance to cisplatin through the activation of the IGFIR/Akt pathway in non-small cell lung cancer.
Authors:	Cortés-Sempere, M¹, de Miguel, M P², Pernía, O³, Rodriguez, C³, de Castro Carpeño, J⁴, Nistal, M⁵, Conde, E⁶, López-Ríos, F⁶, Belda-Iniesta, C⁷, Perona, R¹, de Caceres, I Ibanez³
Source:	Oncogene. 3/7/2013, Vol. 32 Issue 10, p1274-1283. 10p. 1 Color Photograph, 1 Black and White Photograph, 1 Diagram, 3 Graphs.
Database:	Academic Search Ultimate

Description
ISSN:	09509232
DOI:	10.1038/onc.2012.146